209 related articles for article (PubMed ID: 20814352)
1. Biomarkers as a tool for management of immunosuppression in transplant patients.
Wieland E; Olbricht CJ; Süsal C; Gurragchaa P; Böhler T; Israeli M; Sommerer C; Budde K; Hartmann B; Shipkova M; Oellerich M
Ther Drug Monit; 2010 Oct; 32(5):560-72. PubMed ID: 20814352
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.
Millán O; Urtasun N; Brunet M
Transplant Rev (Orlando); 2009 Apr; 23(2):120-8. PubMed ID: 19298943
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry-based pharmacodynamic monitoring after organ transplantation.
Dieterlen MT; Eberhardt K; Tarnok A; Bittner HB; Barten MJ
Methods Cell Biol; 2011; 103():267-84. PubMed ID: 21722807
[TBL] [Abstract][Full Text] [Related]
4. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
Barraclough KA; Staatz CE; Isbel NM; McTaggart SJ
Nephrology (Carlton); 2010 Aug; 15(5):522-32. PubMed ID: 20649871
[TBL] [Abstract][Full Text] [Related]
5. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.
Israeli M; Ben-Gal T; Yaari V; Valdman A; Matz I; Medalion B; Battler A; Sredni B; Kristt D; Klein T
Transplantation; 2010 Apr; 89(8):968-76. PubMed ID: 20075792
[TBL] [Abstract][Full Text] [Related]
6. Finding the right time for weaning off immunosuppression in solid organ transplant recipients.
Orlando G
Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553
[TBL] [Abstract][Full Text] [Related]
7. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
8. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
[TBL] [Abstract][Full Text] [Related]
9. Target enzyme activity as a biomarker for immunosuppression.
Glander P; Budde K
Ther Drug Monit; 2010 Jun; 32(3):257-60. PubMed ID: 20431505
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of over-immunosuppression.
Budde K; Matz M; Dürr M; Glander P
Clin Pharmacol Ther; 2011 Aug; 90(2):316-22. PubMed ID: 21716278
[No Abstract] [Full Text] [Related]
11. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.
Säemann MD; Sunder-Plassmann G
Transpl Immunol; 2008 Nov; 20(1-2):14-20. PubMed ID: 18804533
[TBL] [Abstract][Full Text] [Related]
12. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
[TBL] [Abstract][Full Text] [Related]
14. Current and evolving immunosuppressive regimens in kidney transplantation.
Gaston RS
Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S3-21. PubMed ID: 16567239
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of immune monitoring in solid organ transplantation.
Daniel V; Opelz G
Int Rev Immunol; 2009; 28(3-4):155-84. PubMed ID: 19811320
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.
Taylor AL; Watson CJ; Bradley JA
Crit Rev Oncol Hematol; 2005 Oct; 56(1):23-46. PubMed ID: 16039869
[TBL] [Abstract][Full Text] [Related]
17. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
18. Developing a tool for noninvasive monitoring of renal allografts.
Schaub S; Wilkins JA; Rush D; Nickerson P
Expert Rev Proteomics; 2006 Oct; 3(5):497-509. PubMed ID: 17078764
[TBL] [Abstract][Full Text] [Related]
19. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients.
Zeevi A; Britz JA; Bentlejewski CA; Guaspari D; Tong W; Bond G; Murase N; Harris C; Zak M; Martin D; Post DR; Kowalski RJ; Elmagd KA
Transpl Immunol; 2005 Oct; 15(1):17-24. PubMed ID: 16223669
[TBL] [Abstract][Full Text] [Related]
20. Immunological risk factors for infection after immunosuppressive and biologic therapies.
Carbone J; del Pozo N; Gallego A; Sarmiento E
Expert Rev Anti Infect Ther; 2011 Apr; 9(4):405-13. PubMed ID: 21504398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
